
A new not-for-profit marketing and comms consultancy that specialises in healthcare and research has added Professor Martin Gibson to its …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

